ATIVIDADES COM PARTICIPAÇÃO DA INDÚSTRIA

A seguir, apresentamos atividades científicas inovadoras com o apoio da indústria, abordando os temas mais relevantes da cardiologia intervencionista na atualidade.

Inscrições para o SOLACI-SOCIME 2025

*Todos os simpósios patrocinados ocorrerão das 13h30 às 14h30.
*Informações preliminares.

QUARTA-FEIRA, 6 DE AGOSTO

01.30 pm - Main Arena

	10'	Lifetime management of TAVI patient with Importance of Intermediate and XL sizes of Novel Baloon THV Myval Octacor
	10'	Landmark Updates and Deepdive Session
	10'	My Experience with Myval Octacor (Complicated Case Presentation)
	10'	3 Years Compare TAVI Update
	10'	Discussion

01.30 pm - Sala A1

How OCT and the Ultreon 2.0 imaging software can help you perform PCI in Calcified Lesions
	10'	Unlocking the Power of Ultreon 2.0.
	10'	Seeing the Unseen: OCT in Calcium Detection and Treatment Planning
	10'	Clinical Case Illustration
	10'	Clinical Case Illustration
	10'	Discussion

01.30 pm - Sala A3

QUINTA-FEIRA, 7 DE AGOSTO

01.30 pm - Sala A1

Transforming PE Care: Treating with a Lytic Free Approach and Large-Bore Mechanical Thrombectomy
	5'	Welcome and Opening Remarks
	15'	Why Intervene: The clinical case for mechanical thrombectomy in PE
	15'	From Diagnosis to Treatment: A practical approach to treating patients with large-bore device, FlowTriever
	15'	Driving better outcomes through program building and multidisciplinary collaboration
	10'	Q&A Panel Session

01.30 pm - Sala A2

P-Valve in Focus: A Decade of Evolving Solutions for RVOT Dysfunction
	15'	Advanced Imaging in PPVI: Optimizing Outcomes
	15'	A-to-Z with P-Valve-The TPVI Procedure
	15'	Built to Last: P-Valve in Complex TPVI
	15'	VenusP – A Decade of Data and the Road Ahead

01.30 pm - Sala A3

Transforming PCI: Mastering the implementation of drug-eluting balloons (DEB)
		Welcome & Framing
		The Evidence Base. Rationale and key clinical trials supporting DEBs
		Clinical Applications. Use in standard vs. complex lesions
		Mechanistic Rationale. Drug delivery, vessel healing, and drug choice
		Comparative Perspectives. DEBs vs. stents: when to choose what
		Panel Q&A
		Closing Remarks

01.30 pm - Sala B1

Tricuspid Regurgitation: The Forgotten Valve No More!
	5'	Welcome
	20'	The Rise of a Disruptive Technology
	10'	Latest Evidence and Key Clinical Cases
		Expert Panel: Case Discussion and Clinical Insights
	10'	Case 1
	10'	Case 2
	5'	Audience Q&A
	5'	Session Closure

01.30 pm - Sala B2

The Interventional Cardiology “State of mind” based on clinical cases discussion
	25'	Feasibility of coronary access post TAVI is based on bioprosthetic design: Myth or Fact?
	25'	Understanding the technique of PCI with DCB: Should we change our approach and expectations?
	10'	Discussion

SEXTA-FEIRA, 8 DE AGOSTO

02.00 pm - MAIN ARENA

Venus Aortic Lunch Symposium
	25'	PowerX in Action: Live in a Box
	25'	PowerX: Next Generation Self-Expandable Valve
	10'	12 Years of VenusA Pro: What Long-Term Data Tells Us
	25'	Vitae: First Clinical Experience

• Tweet